http://www.blogtalkradio.com/facesoftbi/2018/02/22/regenerat…ira-pastor
Category: life extension – Page 547
Waiting on research advances is the rationale behind cryopreservation, and more broadly, a worldview known as transhumanism. A person killed by cancer or heart disease could reasonably be revived in a future when such ailments no longer exist. “They believe in the advance of technology,” says Giuseppe Nucci, an Italian photographer who visited with transhumanists and toured the facilities of Russia-based cryonics company KrioRus. “They hope that someone will wake them up.”
This hope, that the future will vanquish the ills of the present, is as old as the first civilisations that realized that with each passing year life got a little better. The Russian philosopher Nikolai Fedorovich Fedorov helped create an early 20th-century movement known as cosmism that was rooted in the idea that, given enough time, humans could defeat evil and death. If the human life span was too short, then the simple solution was to extend it, even after death, and suspend its decomposition until the world caught up.
Employees of a liquid nitrogen and dry ice factory on the outskirts of Moscow are shrouded in fog while refilling their liquid nitrogen tanks. Founded by former KrioRus employees, the company now supplies them. PHOTOGRAPH BY GIUSEPPE NUCCI
Read more
New targeted cancer therapies have emerged to fight tumors, and scientists have much more in the pipeline.
Summary: New targeted cancer therapies have been highlighted this month as emerging technologies to fight tumors, and scientists have much more in the pipeline. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]
Targeted cancer therapies – the most famous of which are immunotherapies such as CAR T-cell therapy – are the current focus of excitement in cancer treatment. New therapies and developments in the immunotherapy field prompted the National Cancer Institute (NCI) to update their guidance on targeted cancer therapies a little over a week ago. As the NCI says.
“Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer.”
Read more
Summary: Cancer immunotherapy treatments and other approaches to cure nearly all cancers within 8 years says Dr. Gilliland, a prominent cancer research head. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]
Gary Gilliland, M.D., Ph.D. is the President and Director, Fred Hutchinson Cancer Research Center and in an opinion piece published at the beginning of this month, writes.
“I’ve gone on record to say that by 2025, cancer researchers will have developed curative therapeutic approaches for most if not all cancers.”
Read more
Team paves the way for cancer immunotherapy demonstrating a novel technique that attacked tumors and inhibited cancers from spreading.
Summary: Team paves the way for cancer immunotherapy with a novel technique that attacked tumors and inhibited cancers from spreading. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]
While cancer immunotherapy is a powerful treatment for some types of tumors, up until now, it hasn’t worked well on colon cancer.
However, a team of researchers in Barcelona just showed a new technique that allows the immune system to recognize and begin fighting the tumor in mice. The treatment was so successful that it inhibited the tumors from spreading, or metastasizing to other parts of the body – as cancer is prone to do. Moreover, for those cancers that had already spread, the treatment enabled the immune system to eliminate them quickly.
Read more
AI and blockchain, the main innovations in #Longevity, are united in DAYS.exchange platform.
DAYS tokens are to be sort of guarrantee for longevity services effectiveness.
DAYS.exchange partner supported Longevity Impact Forum.
The first step to rhe most effective healthcare, based on blockchain consensus regarding health span technologies.
Thanks omar fogliadini, ondřej pilný, ben kraus, alex lightman, avi roy, liz parrish, george kyriakos sergei sevriugin edgar kampers kirill zhukov philippe van nedervelde anton dziatkovskii darr aita.
Read more
Longevity become hottest object for investments;
Startup founded 5 moths ago just raised $250 million.
The start-up, which launched in September and is headquartered in Warren, N.J., announced Thursday it has raised $250 million in venture capital from global biopharmaceutical company Celgene, biotechnology company United Therapeutics Corporation, biopharmaceutical company Sorrento Therapeutics, DNA sequencing and machine learning company Human Longevity, Inc.
Its biological “Band-Aids” are used to accelerate the treatment of wounds and burns resulting from injury or any manner of reconstructive surgery, and its injectable stem cell products can accelerate the repair of a tissue or organ. These restorative products cost from a few hundred to a few thousand dollars per unit, according to Hariri. Celularity bought its stem cell bandage business earlier in January when it acquired Alliqua BioMedical for $29 million.
Read more